Insider Transactions in Q2 2023 at Voyager Therapeutics, Inc. (VYGR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Todd Alfred Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.11%
|
$55,000
$11.41 P/Share
|
|
Jun 30
2023
|
Todd Alfred Carter Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.63%
|
$10,000
$2.85 P/Share
|
|
Apr 03
2023
|
Alfred Sandrock President and CEO |
SELL
Open market or private sale
|
Direct |
7,437
-3.35%
|
$52,059
$7.83 P/Share
|
|
Apr 03
2023
|
Robin Swartz Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,259
-1.73%
|
$8,813
$7.83 P/Share
|